Mechanism of trifluoromethionine resistance in Entamoeba histolytica

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 9, 2011, Pages 2045-2052

  Penuliar, Gil M ^a,b,c   Furukawa, Atsushi ^a,b   Sato, Dan ^d   Nozaki, Tomoyoshi ^a,e  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c University of the Philippines Diliman   (Philippines)

^d KEIO UNIVERSITY   (Japan)

^e UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Amoebiasis; Drug resistance; Methionine lyase

Indexed keywords

ANTIAMEBIC AGENT; CHLOROQUINE; METHIONINE; METHIONINE GAMMA LYASE; METRONIDAZOLE; PAROMOMYCIN; TINIDAZOLE; TRIFLUOROMETHIONINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIPARASITIC RESISTANCE; ARTICLE; CELL ADHESION; CROSS RESISTANCE; CYTOLYSIS; DRUG RESISTANCE; ENTAMOEBA HISTOLYTICA; ENZYME ACTIVITY; GENE SILENCING; IC 50; NONHUMAN; PARASITE VIRULENCE; TROPHOZOITE;

ANIMALS; ANTIPROTOZOAL AGENTS; BLOTTING, WESTERN; CARBON-SULFUR LYASES; CELL ADHESION; CHO CELLS; CRICETINAE; CRICETULUS; CULTURE MEDIA; DRUG RESISTANCE; ELECTROPHORESIS, AGAR GEL; ENTAMOEBA HISTOLYTICA; GENE EXPRESSION REGULATION; GENE SILENCING; KINETICS; METHIONINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 80051684111     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr238     Document Type: Article

References (42)

1. Davis A, Pawlowski ZS. Amoebiasis and its control. Bull World Health Organ 1985; 63: 417-26.
2. Bruckner DA. Amebiasis. Clin Microbiol Rev 1992; 5: 356-69.
3. Araujo J, García M, Díaz-Suá rez O et al. Amebiasis: relevance of its diagnosis and treatment. Invest Clin 2008; 49: 265-71.
4. Pittman FE, Pittman JC. Amebic liver abscess following metronidazole therapy for amebic colitis. Am J Trop Med 1974; 23: 146-50.
5. Griffin FM. Failure of metronidazole to cure hepatic amebic abscess. N Engl J Med 1973; 288: 1397.
6. Wassmann C, Bruchhaus I. Superoxide dismutase reduces susceptibility to metronidazole of the pathogenic protozoan Entamoeba histolytica under microaerophilic but not under anaerobic conditions. Arch Biochem Biophys 2000; 376: 236-8.
7. Wassmann C, Hellberg A, Tannich E et al. Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of iron-containing superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and flavin reductase. J Biol Chem 1999; 274: 26051-6.
8. Upcroft JA, Dunn LA, Wal T et al. Metronidazole resistance in Trichomonas vaginalis from highland women in Papua New Guinea. Sex Health 2009; 6: 334-8.
9. Mü ller J, Sterk M, Hemphill A et al. Characterization of Giardia lamblia WB C6 clones resistant to nitazoxanide and to metronidazole. J Antimicrob Chemother 2007; 60: 280-7.
10. Zygmunt WA, Tavormina PA. DL-S-Trifluoromethylhomocysteine, a novel inhibitor of microbial growth. Can J Microbiol 1966; 12: 143-8.
11. Esaki N, Soda K. L-Methionine g-lyase from Pseudomonas putida and Aeromonas. Methods Enzymol 1987; 143: 459-65.
12. Coombs GH, Mottram JC. Trifluoromethionine, a prodrug designed against methionine g-lyase-containing pathogens, has efficacy in vitro and in vivo against Trichomonas vaginalis. Antimicrob Agents Chemother 2001; 45: 1743-5.
13. Sato D, Yamagata W, Harada S et al. Kinetic characterization of methionine g-lyases from the enteric protozoan parasite Entamoeba histolytica against physiological substrates and trifluoromethionine, a promising lead compound against amoebiasis. FEBS J 2008; 275: 548-60.
14. Sato D, Kobayashi S, Yasui H et al. Cytotoxic effect of amide derivatives of trifluoromethionine against the enteric protozoan parasite Entamoeba histolytica. Int J Antimicrob Agents 2010; 35: 56-61.
15. Alston TA, Bright HJ. Conversion of trifluoromethionine to a cross-linking agent by γ-cystathionase. Biochem Pharmacol 1983; 32: 947-50.
16. Diamond LS, Harlow DR, Cunnick CC. A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans R Soc Trop Med Hyg 1978; 72: 431-2.
17. Strober W. Trypan blue exclusion test of cell viability. Curr Protoc Immunol 2001; A.3B.1-2.
18. Petri WA Jr, Ravdin JI. Protection of gerbils from amebic liver abscess by immunization with the galactose-specific adherence lectin of Entamoeba histolytica. Infect Immun 1991; 59: 97-101.
19. Ravdin JI, Guerrant RL. Role of adherence in cytopathogenic mechanisms of Entamoeba histolytica. Study with mammalian tissue culture cells and human erythrocytes. J Clin Invest 1981; 68: 1305-13.
20. Hellberg A, Nickel R, Lotter H et al. Overexpression of cysteine proteinase 2 in Entamoeba histolytica or Entamoeba dispar increases amoeba-induced monolayer destruction in vitro but does not augment amoebic liver abscess formation in gerbils. Cell Microbiol 2001; 3: 13-20.
21. Hellberg A, Leippe M, Bruchhaus I. Two major 'higher molecular mass proteinases' of Entamoeba histolytica are identified as cysteine proteinases 1 and 2. Mol Biochem Parasitol 2000; 105: 305-9.
22. Tokoro M, Asai T, Kobayashi S et al. Identification and characterization of two isoenzymes of methionine g-lyase from Entamoeba histolytica: a key enzyme of sulfur-amino acid degradation in an anaerobic parasitic protist that lacks forward and reverse trans-sulfuration pathways. J Biol Chem 2003; 278: 42717-27.
23. Bracha R, Nuchamowitz Y, Mirelman D. Transcriptional silencing of an amoebapore gene in Entamoeba histolytica: molecular analysis and effect on pathogenicity. Eukaryot Cell 2003; 2: 295-305.
24. Nakada-Tsukui K, Okada H, Mitra BN et al. Phosphatidylinositolphosphates mediate cytoskeletal reorganization during phagocytosis via a unique modular protein consisting of RhoGEF/DH and FYVE domains in the parasitic protozoon Entamoeba histolytica. Cell Microbiol 2009; 11: 1471-91.
25. Freitas MA, Fernandes HC, Calixto VC et al. Entamoeba histolytica: cysteine proteinase activity and virulence. Focus on cysteine proteinase 5 expression levels. Exp Parasitol 2009; 122: 306-9.
26. Tillack M, Nowak N, Lotter H et al. Increased expression of the major cysteine proteinases by stable episomal transfection underlines the important role of EhCP5 for the pathogenicity of Entamoeba histolytica. Mol Biochem Parasitol 2006; 149: 58-64.
27. Löfmark S, Edlund C, Nord CE. Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis 2010; 50 Suppl 1: S16-23.
28. Alekshun MN, Levy SB. Molecular mechanisms of antibacterial multidrug resistance. Cell 2007; 128: 1037-50.
29. Andersson DI. The biological cost of mutational antibiotic resistance: any practical conclusions? Curr Opin Microbiol 2006; 9: 461-5.
30. Massey RC, Buckling A, Peacock SJ. Phenotypic switching of antibiotic resistance circumvents permanent costs in Staphylococcus aureus. Curr Biol 2001; 11: 1810-4.
31. Jiang H, Patel JJ, Yi M et al. Genome-wide compensatory changes accompany drug-selected mutations in the Plasmodium falciparum crt gene. PLoS One 2008; 3: e2484.
32. Ma C, Tran J, Li C et al. Secondary mutations correct fitness defects in Toxoplasma gondii with dinitroaniline resistance mutations. Genetics 2008; 180: 845-56.
33. Upcroft JA, Upcroft P. Drug resistance and Giardia. Parasitol Today 1993; 9: 187-90.
34. Bech-Hansen NT, Till JE, Ling V. Pleiotropic phenotype of colchicine-resistant CHO cells: cross-resistance and collateral sensitivity. J Cell Physiol 1976; 88: 23-31.
35. Dannley RL, Taborsky RG. Synthesis of DL-S-trifluoromethylhomocysteine (trifluoromethylmethionine). J Organic Chem 1957; 22: 1275-6.
36. Flores-Romo L, Estrada-García T, Shibayama-Salas M et al. In vitro Entamoeba histolytica adhesion to human endothelium: a comparison using two strains of different virulence. Parasitol Res 1997; 83: 397-400.
37. Giha HA, Elbashir MI, A-Elbasit IE et al. Drug resistance-virulence relationship in Plasmodium falciparum causing severe malaria in an area of seasonal and unstable transmission. Acta Trop 2006; 97: 181-7.
38. Landowski TH, Olashaw NE, Agrawal D et al. Cell adhesion-mediated drug resistance (CAM-DR) is associated with activation of NF-kB (RelB/p50) in myeloma cells. Oncogene 2003; 22: 2417-21.
39. Nowak N, Lotter H, Tannich E et al. Resistance of Entamoeba histolytica to the cysteine proteinase inhibitor E64 is associated with secretion of pro-enzymes and reduced pathogenicity. Biol Chem 2004; 279: 38260-6.
40. Adam M, Murali B, Glenn NO et al. Epigenetic inheritance based evolution of antibiotic resistance in bacteria. BMC Evol Biol 2008; 8: 52.
41. Nyce J. Drug-induced DNA hypermethylation and drug resistance in human tumors. Cancer Res 1989; 49: 5829-36.
42. Huguenin M, Bracha R, Chookajorn T et al. Epigenetic transcriptional gene silencing in Entamoeba histolytica: insight into histone and chromatin modifications. Parasitology 2010; 137: 619-27.